CIK 0001759655 · Large accelerated filer
Privia Health Group, Inc.
Sign in to watch- Ticker
- PRVA
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 571-366-8850
- Business address
- 950 N. GLEBE RD., SUITE 700, ARLINGTON, VA, 22203
- Former names
- PH Group Parent Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-27 | Mountcastle David EVP & Chief Financial Officer | Sale 10b5-1 | −7,697 | $25.05 | $193K | 172,909 |
| 2026-02-27 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −998 | 2,835 | ||
| 2026-02-27 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −2,699 | 8,653 | ||
| 2026-02-27 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −3,428 | 12,499 | ||
| 2026-02-27 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −572 | 1,594 | ||
| 2026-02-27 | Morris Matthew Shawn Director | Option exercise 10b5-1 | +16,550 | $2.00 | $33K | 84,738 |
| 2026-02-27 | Morris Matthew Shawn Director | Sale 10b5-1 | −16,550 | $25.00 | $414K | 68,188 |
| 2026-02-27 | Morris Matthew Shawn Director | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −16,550 | 3,692,314 | ||
| 2026-02-26 | Mountcastle David EVP & Chief Financial Officer | Option exercise 10b5-1 | +5,361 | $2.00 | $11K | 178,270 |
| 2026-02-26 | Mountcastle David EVP & Chief Financial Officer | Sale 10b5-1 | −5,361 | $25.00 | $134K | 172,909 |
| 2026-02-26 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −1,668 | 3,833 | ||
| 2026-02-26 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −1,100 | 11,352 | ||
| 2026-02-26 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −1,893 | 15,927 | ||
| 2026-02-26 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −700 | 2,166 | ||
| 2026-02-26 | Morris Matthew Shawn Director | Option exercise 10b5-1 | +7,788 | $2.00 | $16K | 75,976 |
| 2026-02-26 | Morris Matthew Shawn Director | Sale 10b5-1 | −7,788 | $24.99 | $195K | 68,188 |
| 2026-02-26 | Morris Matthew Shawn Director | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −7,788 | 3,708,864 | ||
| 2025-12-12 | Mountcastle David EVP & Chief Financial Officer | Option exercise 10b5-1 | +23,887 | $2.00 | $48K | 196,796 |
| 2025-12-12 | Mountcastle David EVP & Chief Financial Officer | Sale 10b5-1 | −23,887 | $25.03 | $598K | 172,909 |
| 2025-12-12 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −7,698 | 17,820 |
Page 5 of 11 · 214 trades